ストックスクリーナーアプリを入手
14.93
5.59%
0.79
アフターアワーズ：
14.93
前日終値:
$14.14
開ける：
$13.55
24時間の取引高:
1.53M
Relative Volume:
2.38
時価総額：
$1.77B
収益：
$628.25M
当期純損益:
$-78.55M
株価収益率:
-19.39
EPS:
-0.77
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
+10.43%
1か月 パフォーマンス:
+7.10%
6か月 パフォーマンス:
-2.42%
1年 パフォーマンス:
-2.23%
1日の値動き範囲:
$13.35
$15.08
1週間の範囲:
$13.21
$15.08
52週間の値動き範囲:
$12.77
$21.22
Neogenomics Inc Stock (NEO) Company Profile
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics: Q3 Earnings Snapshot - The Washington Post
NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
NeoGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Emerald Mutual Fund Advisers Trust Sells 314,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
Blue Trust Inc. Boosts Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics (NEO) to Release Earnings on Tuesday - MarketBeat
NeoGenomics gains conditional approval for solid tumour assays in New York - Medical Device Network
NeoGenomics NGS tests gain New York State approval - Investing.com
NEONeoGenomics, Inc. Latest Stock News & Market Updates - StockTitan
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire
Truist Financial Corp Sells 4,699 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics (NASDAQ:NEO) Shares Down 2.5%Should You Sell? - MarketBeat
Is NeoGenomics (NASDAQ:NEO) A Risky Investment? - Simply Wall St
Neogenomics Inc. (NEO) gets rating Resumed from Craig Hallum - Knox Daily
NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 - BioSpace
Analytical Lens: Exploring Neogenomics Inc. (NEO)’s Financial Story Through Ratios - The Dwinnex
Check out these key findings about Neogenomics Inc. (NEO) - SETE News
Renaissance Technologies LLC Cuts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
(NEO) Technical Data - Stock Traders Daily
Breast Cancer Liquid Biopsy Market is expected to Double Its Size - openPR
NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
NEO (Neogenomics Inc.) may reap gains as insiders became active recently - Knox Daily
Neogenomics Inc. (NEO)’s results reveal risk - US Post News
Insider’s View: Deciphering Neogenomics Inc. (NEO)’s Financial Health Through Ratios - The Dwinnex
Anatomic Pathology Market Is Expected To Grow Exponentially By The 2031 | Inc., Bio SB, Biogenex Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG., Laboratory Corporation of America Holdings, Neogenomics Laboratories – Times-BD24 - Times-BD24
NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research
NeoGenomics Unveils AML Express - Baystreet.ca
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia - Business Wire
Is Neogenomics Inc. (NEO) positioned for future growth? - SETE News
Did Neogenomics Inc. (NEO) perform well in the last session? - US Post News
Sei Investments Co. Has $3.66 Million Position in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
Sei Investments Co. Boosts Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
Recent Insider Activity Suggests Potential Gains for Neogenomics Inc. (NEO) - Knox Daily
NeoGenomics Becomes Oversold (NEO) - Nasdaq
Point72 Asset Management L.P. Reduces Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
NeoGenomics (NASDAQ:NEO) Stock Price Down 6.4% - Defense World
Financial Fitness Check: Examining Neogenomics Inc. (NEO)’s Key Ratios - The Dwinnex
It is Poised to be a Bull Market for Neogenomics Inc. (NEO) - SETE News
Public Employees Retirement Association of Colorado Decreases Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
NeoGenomics, Inc. (NASDAQ:NEO) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
FY2024 Earnings Estimate for NeoGenomics, Inc. Issued By William Blair (NASDAQ:NEO) - MarketBeat
Brokers Offer Predictions for NeoGenomics, Inc.'s Q4 2025 Earnings (NASDAQ:NEO) - MarketBeat
Cancer Tumor Profiling Market Company Profiles, Segments, - openPR
Fred Alger Management LLC Sells 504,854 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
NeoGenomics (NASDAQ:NEO) Rating Reiterated by Needham & Company LLC - MarketBeat
Benchmark maintains Buy rating on Neogenomics stock - Investing.com
Neogen (NASDAQ:NEOG) Stock Price Down 4% - Defense World
Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail
First Light Asset Management LLC Acquires 480,396 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
3.48%
0.04%
大文字化:
|
ボリューム (24 時間):